Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy

Chest

Volumn 141, Issue 1, 2012, Pages 27-35

  Kerr, Kim M ^a   Auger, William R ^a   Marsh, James J ^a   Devendra, Gehan ^c   Spragg, Roger G ^a   Kim, Nick H ^a   Channick, Richard N ^d   Jamieson, Stuart W ^a   Madani, Michael M ^a   Manecke, Gerard R ^b   Roth, David M ^b   Shragg, Gordon P ^a   Fedullo, Peter F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c KAISER PERMANENTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; PLACEBO;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CARDIOPULMONARY BYPASS; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDARTERECTOMY; FEMALE; HUMAN; INFECTION; INTENSIVE CARE; LENGTH OF STAY; LUNG INJURY; LUNG INJURY SCORE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; PERICARDITIS; PLEUROPERICARDITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULMONARY THROMBOENDARTERECTOMY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 84855462945     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2639     Document Type: Article

References (20)

1. Kerr KM, Auger WR, Marsh JJ, et al. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 2000;162(1):14-20. (Pubitemid 30469791)
2. Adams A, Fedullo PF. Postoperative management of the patient undergoing pulmonary endarterectomy. Semin Thorac Cardiovasc Surg. 2006;18(3):250-256. (Pubitemid 44914577)
3. Levinson RM, Shure D, Moser KM. Reperfusion pulmonary edema after pulmonary artery thromboendarterectomy. Am Rev Respir Dis. 1986;134(6):1241- 1245. (Pubitemid 17216905)
4. Jorens PG, De Jongh R, De Backer W, et al. Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. Am Rev Respir Dis. 1993;148(4 pt 1):890-895. (Pubitemid 23301202)
5. Hill GE, Alonso A, Spurzem JR, Stammers AH, Robbins RA. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg. 1995;110(6):1658-1662. (Pubitemid 3020548)
6. Engelman RM, Rousou JA, Flack JE III, Deaton DW, Kalfin R, Das DK. Influence of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg. 1995;60(3):801-804.
7. Tassani P, Richter JA, Barankay A, et al. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures? J Cardiothorac Vasc Anesth. 1999;13(2):165-172. (Pubitemid 29204942)
8. Celik JB, Gormus N, Okesli S, Gormus ZI, Solak H. Methylprednisolone prevents inflammatory reaction occurring during cardiopulmonary bypass: Effects on TNF-α, IL-6, IL-8, IL-10. Perfusion. 2004;19(3):185-191. (Pubitemid 39028946)
9. Whitlock RP, Chan S, Devereaux PJ, et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: A meta-analysis of randomized trials. Eur Heart J. 2008;29(21):2592-2600.
10. Manecke GR Jr. Anesthesia for pulmonary endarterectomy. Semin Thorac Cardiovasc Surg. 2006;18(3):236-242.
11. Thistlethwaite PA, Kaneko K, Madani MM, Jamieson SW. Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg. 2008;14(5):274-282.
12. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720-723.
13. Auger WR, Kim NH, Kerr KM, Test VJ, Fedullo PF. Chronic thromboembolic pulmonary hypertension. Clin Chest Med. 2007;28(1):255-269. (Pubitemid 46330546)
14. Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: Experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76(5):1457-1462.
15. Chaney MA. Corticosteroids and cardiopulmonary bypass: a review of clinical investigations. Chest. 2002;121(3):921-931. (Pubitemid 34251460)
16. Langer F, Schramm R, Bauer M, Tscholl D, Kunihara T, Schäfers HJ. Cytokine response to pulmonary thromboendarterectomy. Chest. 2004;126(1):135-141. (Pubitemid 38943129)
17. Liakopoulos OJ, Schmitto JD, Kazmaier S, et al. Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. Ann Thorac Surg. 2007;84(1):110-118.
18. Warren OJ, Smith AJ, Alexiou C, et al. The inflammatory response to cardiopulmonary bypass: part 1-mechanisms of pathogenesis. J Cardiothorac Vasc Anesth. 2009;23(2):223-231.
19. Coffin LH, Shinozaki T, DeMeules JE, Browdie DA, Deane RSD, Morgan JG. Ineffectiveness of methylprednisolone in the treatment of pulmonary dysfunction after cardiopulmonary bypass. Am J Surg. 1975;130(5):555-559.
20. Chaney MA, Nikolov MP, Blakeman B, Bakhos M, Slogoff S. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg. 1998;87(1):27-33. (Pubitemid 28311605)